| Business Name: |
Lazarus Therapeutics Inc |
| Contact Person: |
Geraldine Henwood |
| Address: |
55 Valley Stream Parkway, Malvern, Pennsylvania 19355 |
| Phone Number: |
(484) 395-2400 |
| Website Address: |
malvernconsultinggroup.com |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2006 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B & B2C |
| Business Category: |
|
| SIC Code: |
2834 |
| NAICS Code: |
325412 |
| Share This Business: |
|
| Related Businesses: |
Janssen Biotech Inc - Malvern, PA 19355
Crixmor LLC - Malvern, PA 19355
Recro Pharma Inc - Malvern, PA 19355
Janssen Biotech Inc - Malvern, PA 19355
DermAvance Pharmaceuticals - Malvern, PA 19355
Viropharma Incorporated - Malvern, PA 19355
Janssen Biotech Inc - Malvern, PA 19355
Janssen Biotech - Malvern, PA 19355
Vicept Therapeutics Inc - Malvern, PA 19355
Cephalon International Holdings Inc - Malvern, PA 19355
Promedior Inc - Malvern, PA 19355
Fred Oakes - Malvern, PA 19355
Endo Pharmaceuticals Inc - Malvern, PA 19355
Teva Pharmaceuticals USA Inc - Malvern, PA 19355
Endo Pharmaceuticals Solutions Inc - Malvern, PA 19355
Micron Technologies - Malvern, PA 19355
Qilu Pharma Inc - Malvern, PA 19355
Zeomedix Inc - Malvern, PA 19355
|
The company Lazarus Therapeutics Inc provides BOTH services in the form of from its single location in Pennsylvania.
1 to 4 employees work for Lazarus Therapeutics Inc, and the business now earns $100.000 to $499.999 per annum.
Lazarus Therapeutics Inc was launched in 2006 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 .
To contact Lazarus Therapeutics Inc, please call Geraldine Henwood with the phone number (484) 395-2400 or visit its single location at 55 Valley Stream Parkway in Malvern, Pennsylvania 19355.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage malvernconsultinggroup.com or follow the company’s social media accounts, on Twitter and on Facebook.